// App-Quantinova.ai

PB2450 : Antithrombin III Levels Immediately Following Acute Venous Thromboembolism

Researchers

Presenter

  • C. Kabrhel

Principal Investigators

  • R. Rosovsky

  • N. Giordano

  • H. Zheng

Medical Centers

  • Massachusetts General Hospital, Emergency Medicine, Boston, United States

  • Harvard Medical School, Hematology, Boston, United States

  • Massachusetts General Hospital, Division of Gastroenterology, Boston, United States

  • Harvard Medical School, Hematology, Boston, United States

  • Massachusetts General Hospital, Biostatistics, Boston, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Antithrombin III

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved